Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis. Chu X, Tian W, Ning J, Zhou R, et al. J Natl Cancer Inst 2024;116:1571-1586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chu X, Tian W, Ning J, Zhou R, et al. Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis. J Natl Cancer Inst 2024;116:1571-1586.
PMID: 38885371